NASDAQ:SOLYSoliton Stock Price, Forecast & News

$9.88

+0.11 (+1.13 %)

(As of 05/28/2020 04:00 PM ET)

Add

Compare

Today's Range

$9.80

Now: $9.88▼

$10.70

50-Day Range

$7.62

MA: $8.91▼

$9.85

52-Week Range

$6.64

Now: $9.88▼

$29.00

Volume153,302 shs

Average Volume76,592 shs

Market Capitalization$167.37 million

P/E RatioN/A

Dividend YieldN/A

Beta0.23

Soliton, Inc., an early stage medical device company, focuses on developing and commercializing products using a proprietary rapid acoustic pulse technology platform. It offers a device for the removal of tattoos. The company was founded in 2012 and is headquartered in Houston, Texas.

Beat the Market (BTM) Rank^™

3.5 Analyst's Opinion

Consensus Rating
Soliton has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $18.00, Soliton has a potential upside of 82.2% from its current price of $9.88.
Amount of Analyst Coverage
Soliton has only been the subject of 2 research reports in the past 90 days.

2.8 Community Rank

Outperform Votes
Soliton has received 71 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Soliton has received 58 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Soliton has received 55.04% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Soliton and other stocks. Vote “Outperform” if you believe SOLY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe SOLY will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Soliton does not currently pay a dividend.
Dividend Growth
Soliton does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Soliton insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 10.00% of the stock of Soliton is held by insiders.
Percentage Held by Institutions
Only 11.81% of the stock of Soliton is held by institutions.

0.0 Earnings and Valuation

Earnings Growth
Earnings for Soliton are expected to decrease in the coming year, from ($0.75) to ($0.90) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Soliton is -9.88, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Soliton is -9.88, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Soliton has a P/B Ratio of 21.48. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

1.26 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NASDAQ

Industry Surgical & medical instruments

Sub-IndustryN/A

SectorMedical

Current SymbolNASDAQ:SOLY

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.soliton.com

Phone844-705-4866

Debt

Debt-to-Equity RatioN/A

Current Ratio4.68

Quick Ratio4.68

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book Value$0.46 per share

Price / Book21.48

Profitability

EPS (Most Recent Fiscal Year)($1.00)

Net Income$-13,750,000.00

Net MarginsN/A

Return on Equity-154.06%

Return on Assets-121.97%

Miscellaneous

Employees7

Outstanding Shares16,940,000

Market Cap$167.37 million

Next Earnings Date8/13/2020 (Estimated)

OptionableNot Optionable

Receive SOLY News and Ratings via Email

Sign-up to receive the latest news and ratings for SOLY and its competitors with MarketBeat's FREE daily newsletter.

Soliton (NASDAQ:SOLY) Frequently Asked Questions

How has Soliton's stock been impacted by COVID-19 (Coronavirus)?

Soliton's stock was trading at $10.66 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, SOLY shares have decreased by 7.3% and is now trading at $9.88. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Soliton?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Soliton in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Soliton.

When is Soliton's next earnings date?

Soliton is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for Soliton.

How were Soliton's earnings last quarter?

Soliton Inc (NASDAQ:SOLY) announced its earnings results on Thursday, May, 14th. The company reported ($0.19) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.25) by $0.06. View Soliton's earnings history.

What price target have analysts set for SOLY?

2 analysts have issued 12-month price targets for Soliton's stock. Their forecasts range from $14.00 to $22.00. On average, they anticipate Soliton's stock price to reach $18.00 in the next twelve months. This suggests a possible upside of 82.2% from the stock's current price. View analysts' price targets for Soliton.

Has Soliton been receiving favorable news coverage?

Media headlines about SOLY stock have been trending somewhat positive on Friday, according to InfoTrie Sentiment. InfoTrie rates the sentiment of media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Soliton earned a media sentiment score of 0.7 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 2.0 out of 10, meaning that recent media coverage is very unlikely to have an effect on the company's share price in the near term. View the latest news aboutSoliton.

Are investors shorting Soliton?

Soliton saw a increase in short interest during the month of May. As of May 15th, there was short interest totaling 1,120,000 shares, an increase of 8.7% from the April 30th total of 1,030,000 shares. Based on an average trading volume of 143,000 shares, the short-interest ratio is currently 7.8 days. Currently, 19.9% of the shares of the stock are short sold. View Soliton's Current Options Chain.

Who are some of Soliton's key competitors?

Some companies that are related to Soliton include GenMark Diagnostics (GNMK), LeMaitre Vascular (LMAT), SurModics (SRDX), Vapotherm (VAPO), SI-Bone (SIBN), Anika Therapeutics (ANIK), Co-Diagnostics (CODX), Antares Pharma (ATRS), AngioDynamics (ANGO), MiMedx Group (MDXG), Repro-Med Systems (REPR), Repro Med Systems (KRMD), Intersect ENT (XENT), Utah Medical Products (UTMD) and Cytosorbents (CTSO). View all competitors.

What other stocks do shareholders of Soliton own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Soliton investors own include Cronos Group (CRON), Canopy Growth (CGC), NVIDIA (NVDA), Aurora Cannabis (ACB), Tesla (TSLA), Innovative Industrial Properties (IIPR), Micron Technology (MU), Square (SQ), AT&T (T) and Verizon Communications (VZ).

Who are Soliton's key executives?

Soliton's management team includes the following people:

Mr. Walter V. Klemp, Founder & Exec. Chairman (Age 59)
Dr. Christopher C. Capelli, CEO, Pres, Chief Science Officer & Director (Age 59)
Ms. Lori H. Bisson, CFO & Sec. (Age 48)
Mr. Joe D. Tanner, Chief Operating Officer (Age 72)
Mr. Lee Stranathan, Chief Marketing Officer

What is Soliton's stock symbol?

Soliton trades on the NASDAQ under the ticker symbol "SOLY."

Who are Soliton's major shareholders?

Soliton's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (2.47%), Geode Capital Management LLC (0.54%), State Street Corp (0.51%), Nuveen Asset Management LLC (0.30%), Advisor Group Holdings Inc. (0.26%) and Morgan Stanley (0.21%).

Which institutional investors are selling Soliton stock?

SOLY stock was sold by a variety of institutional investors in the last quarter, including Nuveen Asset Management LLC, Morgan Stanley, UBS Group AG, First Trust Advisors LP, and Wells Fargo & Company MN.

Which institutional investors are buying Soliton stock?

SOLY stock was bought by a variety of institutional investors in the last quarter, including Advisor Group Holdings Inc., Matisse Capital, Geode Capital Management LLC, BlackRock Inc., State Street Corp, Bank of New York Mellon Corp, and JPMorgan Chase & Co..

How do I buy shares of Soliton?

Shares of SOLY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Soliton's stock price today?

One share of SOLY stock can currently be purchased for approximately $9.88.

How big of a company is Soliton?

Soliton has a market capitalization of $167.37 million. The company earns $-13,750,000.00 in net income (profit) each year or ($1.00) on an earnings per share basis. Soliton employs 7 workers across the globe.

What is Soliton's official website?

The official website for Soliton is www.soliton.com.

How can I contact Soliton?

Soliton's mailing address is 5304 ASHBROOK DRIVE, HOUSTON TX, 77081. The company can be reached via phone at 844-705-4866.

This page was last updated on 5/29/2020 by MarketBeat.com Staff